Urologia Internationalis

Prostate Cancer

Diagnosis and Staging of Prostatic Carcinoma: What Is Really Necessary?

Schmid H.-P.a · Oberpenning F.a · Pummer K.b

Author affiliations

aDepartment of Urology, Westfälische Wilhelms-University, Münster, Germany; bDepartment of Urology, Karl-Franzens-University, Graz, Austria

Keywords: DiagnosisStagingProstatic carcinomaDigital rectal examinationProstate-specific antigenTransrectal ultrasonographyPelvic lymphadenectomyBone scintigraphy

Related Articles for ""
Urol Int 1999;63:57–61
https://doi.org/10.1159/000030419

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Prostate Cancer

Published online: December 03, 1999
Issue release date: November 1999

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 3

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Diagnosis and staging of prostatic carcinoma should be considered in men in whom treatment with curative intent is possible. The primary tools for detection of cancer are digital rectal examination (DRE) and serum prostate-specific antigen (PSA), whereas transrectal ultrasonography is best used to guide the needle for biopsy. Staging should be based on the TNM system. The most reliable staging methods include a combination of DRE, PSA and systematic biopsies for local tumor extension, pelvic lymphadenectomy for regional lymph nodes, and PSA and bone scintigraphy for distant metastases. Computed tomography and magnetic resonance imaging are not necessary in most cases.

© 1999 S. Karger AG, Basel



Related Articles:

References

  1. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid H-P: Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993;71:933–938.
    External Resources
  2. McNaughton Collins M, Ransohoff DF, Barry MJ: Early detection of prostate cancer. Serendipity strikes again. JAMA 1997;278:1516–1519.
    External Resources
  3. McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TA: Stage A versus stage B adenocarcinoma of the prostate: Morphological comparison and biological significance. J Urol 1988;139:61–65.
    External Resources
  4. Chodak GW: Early detection and screening for prostatic cancer. Urology 1989;34:(suppl 4):10–12.
  5. Pedersen KV, Carlsson P, Varenhorst E, Loefman O, Berglund K: Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. Br J Med 1990;300:1041–1044.
  6. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283–1290.
    External Resources
  7. Semjonow A, Brandt B, Oberpenning F, Roth S, Hertle L: Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values. Prostate 1996;(suppl 7):3–16.
  8. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJJ, Petros JA, Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156–1161.
    External Resources
  9. Haas GP, Montie JE, Pontes JE: The state of prostate cancer screening in the United States. Eur Urol 1993;23:337–347.
    External Resources
  10. Benson MC, Olsson CA: Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management. Cancer 1994;74:1667–1673.
    External Resources
  11. Zlotta AR, Djavan B, Marberger M, Schulman CC: Prostate specific antigen density of the transition zone: A new effective parameter for prostate cancer prediction. J Urol 1997;157:1315–1321.
    External Resources
  12. Partin AW, Criley SR, Subong ENP, Zincke H, Walsh PC, Oesterling JE: Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis. J Urol 1996;155:1336–1339.
    External Resources
  13. Woodrum DL, Brawer MK, Partin AW, Catalona WJ, Southwick PC: Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J Urol 1998;159:5–12.
    External Resources
  14. Froschermaier SE, Pilarsky CP, Wirth MP: Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma. Urology 1996;47:525–528.
    External Resources
  15. Huber PR, Schmid H-P, Mattarelli G, Strittmatter B, van Steenbrugge GJ, Maurer A: Serum free prostate specific antigen: Isoenzymes in benign hyperplasia and cancer of the prostate. Prostate 1995;27:212–219.
    External Resources
  16. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard LJ, Walsh PC: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215–2220.
    External Resources
  17. Schmid H-P, McNeal JE, Stamey TA: Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 1993;71:2031–2040.
    External Resources
  18. Wirth MP, Frohmueller HGW: Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases. Eur Urol 1992;22:27–32.
    External Resources
  19. Mettlin C, Murphy GP, Babaian RJ, Chesley A, Kane RA, Littrup PJ, Mostofi FK, Ray PS, Shanberg AM, Toi A, for the Investigators of the American Cancer Society National Prostate Cancer Detection Project: The results of a five-year early prostate cancer detection intervention. Cancer 1996;77:150–159.
    External Resources
  20. Hodge KK, McNeal JE, Terris MK, Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71–75.
    External Resources
  21. Keetch DW, Catalona WJ, Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994;151:1571–1574.
    External Resources
  22. Lui PD, Terris MK, McNeal JE, Stamey TA: Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 1995;153:1000–1003.
    External Resources
  23. Sobin LH, Wittekind C (eds): TNM Classification of Malignant Tumours, ed 5. New York, Wiley, 1997.
  24. Spigelman SS, McNeal JE, Freiha FS, Stamey TA: Rectal examination in volume determination of carcinoma of the prostate: Clinical and anatomical correlations. J Urol 1986;136:1228–1230.
    External Resources
  25. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110–114.
    External Resources
  26. Rorvik J, Halvorsen OJ, Servoll E, Haukaas S: Transrectal ultrasonography to assess local extent of prostatic cancer before radical prostatectomy. Br J Urol 1994;73:65–69.
    External Resources
  27. Ravery V, Schmid H-P, Toublanc M, Boccon-Gibod L: Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1–T2 prostate carcinoma? Cancer 1996;78:1079–1084.
    External Resources
  28. Rifkin MD, Zerhouni EA, Gatsonis CA, Quint LE, Paushter DM, Epstein JI, Hamper U, Walsh PC, McNeil BJ: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 1990;323:621–626.
    External Resources
  29. Schnall MD, Imai Y, Tomaszewski J, Pollack H, Lenkinski RE, Kressel HY: Prostate cancer: Local staging with endorectal surface coil MR imaging. Radiology 1991;178:797–802.
    External Resources
  30. Hammerer P, Huland H, Sparenberg A: Digital rectal examination, imaging, and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinoma. Eur Urol 1992;22:281–287.
    External Resources
  31. Rana A, Karamanis K, Lucas MG, Chisholm GD: Identification of metastatic disease by T category, Gleason Score and serum PSA level in patients with carcinoma of the prostate. Br J Urol 1992;69:277–281.
    External Resources
  32. Wolff JM, Bares R, Jung PK, Buell U, Jakse G: Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer. Urol Int 1996;56:169–173.
    External Resources
  33. Chybowski FM, Larson Keller JJ, Bergstralh EJ, Oesterling JE: Predicting radionuclide bone scan findings in patients with newly diagnosed untreated prostate cancer: Prostate specific antigen is superior to all other clinical parameters. J Urol 1991;145:313–318.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Prostate Cancer

Published online: December 03, 1999
Issue release date: November 1999

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 3

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

1999, Vol.63, No. 1

November 1999

Article

Recommend This
TOP